ROGLIANI, PAOLA
ROGLIANI, PAOLA
Dipartimento di Medicina Sperimentale
A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD
2013-10-01 Ora, J; Calzetta, L; Pezzuto, G; Senis, L; Paone, G; Mari, A; Portalone, S; Rogliani, P; Puxeddu, E; Saltini, C
A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study
2020-01-01 Calzetta, L; Matera, Mg; Goldstein, Mf; Fairweather, Wr; Howard, Ww; Cazzola, M; Rogliani, P
A narrative review on asthma and pest sensitization (cockroach, mouse and rat allergens): a social issue besides the medical problem
2023-01-01 Liccardi, G; Martini, M; Bilò, Mb; Milanese, M; Calzetta, L; Laitano, R; Rogliani, P
A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD
2009-01-01 Cazzola, M; Rogliani, P; Curradi, G; Segreti, A; Ciaprini, C; Pezzuto, G; Saltini, C
A potential role of triple therapy for asthma patients
2019-01-01 Cazzola, M; Puxeddu, E; Matera, Mg; Rogliani, P
A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD
2018-03-05 Matera, Mg; Calzetta, L; Puxeddu, E; Rogliani, P; Cazzola, M
A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable COPD
2016-01-01 Calzetta, L; Rogliani, P; Matera, M; Cazzola, M
Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease
2013-04-01 Cazzola, M; Rogliani, P; Matera, M
Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients
2022-01-01 Ora, J; Coppola, A; Perduno, A; Manzetti, Gm; Puxeddu, E; Rogliani, P
Acute exacerbations of COPD: Risk factors for failure and relapse
2017-01-01 Mantero, M; Rogliani, P; Di Pasquale, M; Polverino, E; Crisafulli, E; Guerrero, M; Gramegna, A; Cazzola, M; Blasi, F
Adding a LAMA to ICS/LABA therapy: a meta-analysis of triple combination therapy in COPD
2019-01-01 Calzetta, L; Cazzola, M; Matera, Mg; Rogliani, P
Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination
2020-01-01 Rogliani, P; Ritondo, Bl; Zerillo, B; Cazzola, M; Matera, Mg; Calzetta, L
Adherence to COPD treatment: Myth and reality
2017-01-01 Rogliani, P; Ora, J; Puxeddu, E; Matera, M; Cazzola, M
Advances in adrenergic receptors for the treatment of chronic obstructive pulmonary disease: 2023 update
2023-01-01 Matera, Mg; Rinaldi, B; Calzetta, L; Rogliani, P; Cazzola, M
Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond
2014-01-01 Calzetta, L; Rogliani, P; Cazzola, M; Matera, M
Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease
2020-01-01 Cazzola, M; Cavalli, F; Usmani, Os; Rogliani, P
Advances in understanding of mechanisms related to increased cardiovascular risk in COPD
2021-01-01 Rogliani, P; Ritondo, Bl; Laitano, R; Chetta, A; Calzetta, L
Advances with glucocorticoids in the treatment of asthma: state of the art
2020-12-01 Ora, J; Calzetta, L; Matera, Mg; Cazzola, M; Rogliani, P
Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics
2019-01-01 Principe, S; Benfante, A; Calzetta, L; Rogliani, P; Scichilone, N
Airflow obstruction: Is it asthma or is it COPD?
2016-01-01 Rogliani, P; Ora, J; Puxeddu, E; Cazzola, M
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-ott-2013 | A 6MWT index to predict O2 flow correcting exercise induced SpO2 desaturation in ILD | Ora, J; Calzetta, L; Pezzuto, G; Senis, L; Paone, G; Mari, A; Portalone, S; Rogliani, P; Puxeddu, E; Saltini, C | Articolo su rivista | |
| 1-gen-2020 | A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study | Calzetta, L; Matera, Mg; Goldstein, Mf; Fairweather, Wr; Howard, Ww; Cazzola, M; Rogliani, P | Articolo su rivista | |
| 1-gen-2023 | A narrative review on asthma and pest sensitization (cockroach, mouse and rat allergens): a social issue besides the medical problem | Liccardi, G; Martini, M; Bilò, Mb; Milanese, M; Calzetta, L; Laitano, R; Rogliani, P | Articolo su rivista | |
| 1-gen-2009 | A pilot comparison of helium dilution and plethysmographic lung volumes to assess the impact of a long-acting bronchodilator on lung hyperinflation in COPD | Cazzola, M; Rogliani, P; Curradi, G; Segreti, A; Ciaprini, C; Pezzuto, G; Saltini, C | Articolo su rivista | |
| 1-gen-2019 | A potential role of triple therapy for asthma patients | Cazzola, M; Puxeddu, E; Matera, Mg; Rogliani, P | Articolo su rivista | |
| 5-mar-2018 | A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD | Matera, Mg; Calzetta, L; Puxeddu, E; Rogliani, P; Cazzola, M | Articolo su rivista | |
| 1-gen-2016 | A systematic review with meta-analysis of dual bronchodilation with LAMA/LABA for the treatment of stable COPD | Calzetta, L; Rogliani, P; Matera, M; Cazzola, M | Articolo su rivista | |
| 1-apr-2013 | Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease | Cazzola, M; Rogliani, P; Matera, M | Articolo su rivista | |
| 1-gen-2022 | Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients | Ora, J; Coppola, A; Perduno, A; Manzetti, Gm; Puxeddu, E; Rogliani, P | Articolo su rivista | |
| 1-gen-2017 | Acute exacerbations of COPD: Risk factors for failure and relapse | Mantero, M; Rogliani, P; Di Pasquale, M; Polverino, E; Crisafulli, E; Guerrero, M; Gramegna, A; Cazzola, M; Blasi, F | Articolo su rivista | |
| 1-gen-2019 | Adding a LAMA to ICS/LABA therapy: a meta-analysis of triple combination therapy in COPD | Calzetta, L; Cazzola, M; Matera, Mg; Rogliani, P | Articolo su rivista | |
| 1-gen-2020 | Adding a Second Bronchodilator in COPD: A Meta-Analysis on the Risk of Specific Cardiovascular Serious Adverse Events of Tiotropium/Olodaterol Fixed-Dose Combination | Rogliani, P; Ritondo, Bl; Zerillo, B; Cazzola, M; Matera, Mg; Calzetta, L | Articolo su rivista | |
| 1-gen-2017 | Adherence to COPD treatment: Myth and reality | Rogliani, P; Ora, J; Puxeddu, E; Matera, M; Cazzola, M | Articolo su rivista | |
| 1-gen-2023 | Advances in adrenergic receptors for the treatment of chronic obstructive pulmonary disease: 2023 update | Matera, Mg; Rinaldi, B; Calzetta, L; Rogliani, P; Cazzola, M | Articolo su rivista | |
| 1-gen-2014 | Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond | Calzetta, L; Rogliani, P; Cazzola, M; Matera, M | Articolo su rivista | |
| 1-gen-2020 | Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease | Cazzola, M; Cavalli, F; Usmani, Os; Rogliani, P | Articolo su rivista | |
| 1-gen-2021 | Advances in understanding of mechanisms related to increased cardiovascular risk in COPD | Rogliani, P; Ritondo, Bl; Laitano, R; Chetta, A; Calzetta, L | Articolo su rivista | |
| 1-dic-2020 | Advances with glucocorticoids in the treatment of asthma: state of the art | Ora, J; Calzetta, L; Matera, Mg; Cazzola, M; Rogliani, P | Articolo su rivista | |
| 1-gen-2019 | Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics | Principe, S; Benfante, A; Calzetta, L; Rogliani, P; Scichilone, N | Articolo su rivista | |
| 1-gen-2016 | Airflow obstruction: Is it asthma or is it COPD? | Rogliani, P; Ora, J; Puxeddu, E; Cazzola, M | Articolo su rivista |